Effects of Intermittent Fasting on Patients with Immune Thrombocytopenia (ITP) Receiving TPO-RA : Multicenter Mixed-Design Study

被引：0
|
作者：
Yassin, Mohamed A. [1 ]
Al-Rasheed, Mona [2 ]
Al-Eisa, Taghred [3 ]
Al-Hashim, Nora [4 ]
Al Sayegh, Faisal [4 ]
Abu Zaid, Tarek [5 ]
Musa, Heba [6 ]
Alshurafa, Awni [7 ]
Abdelfattah, Mohamed [8 ]
机构：
[1] Natl Ctr Canc Care & Res, Hematol BMT, Doha, Qatar
[2] Hematol Adan Hosp, Kuwait, Kuwait
[3] Jahra Hosp, Hematol Sect, Kuwait, Kuwait
[4] Mubarak Hosp, Hematol, Kuwait, Kuwait
[5] Al Mowasat Hosp, Hematol, Riyadh, Saudi Arabia
[6] Accsight, Cairo, Egypt
[7] Natl Ctr Canc Care Res, Dept Hematol & Bone Marrow Transplant, Doha, Qatar
[8] Accsight, Jeddah, Saudi Arabia
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182824
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 36 条
  • [21] UPDATED RESULTS FROM A LARGE, OBSERVATIONAL STUDY OF PATIENTS (PTS) WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) RECEIVING ROMIPLOSTIM IN EUROPEAN CLINICAL PRACTICE
    Papadaki, H.
    Janssens, A.
    Kaiafa, G.
    Kozak, T.
    Selleslag, D.
    Steurer, M.
    Quittet, P.
    Viallard, J. F.
    Wadenvik, H.
    Belton, L.
    Kreuzbauer, G.
    HAEMATOLOGICA, 2014, 99 : 203 - 203
  • [22] TPO-RECEPTOR AGONISTS AS TREATMENT PREPARING ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA TO SPLENECTOMY. RESULTS OF A RETROSPECTIVE, OBSERVATIONAL STUDY (GIMEMA ITP0614)
    Zaja, F.
    Barcellini, W.
    Cantoni, S.
    Carpenedo, M.
    Caparrotti, G.
    Carrai, V.
    Di Renzo, N.
    Santoro, C.
    Di Nicola, M.
    Veneri, D.
    Simonetti, F.
    Liberati, A. M.
    Ferla, V.
    Paoloni, F.
    Crea, E.
    Tuniz, E.
    Fanin, R.
    HAEMATOLOGICA, 2015, 100 : 58 - 58
  • [23] An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim
    Stasi, Roberto
    Newland, Adrian
    Godeau, Bertrand
    Priego, Victor
    Viallard, Jean-Francois
    Fernandez, Maria Fernanda Lopez
    Jia, Catherine
    Lopez, Angela
    BLOOD, 2013, 122 (21)
  • [24] Rationale and Design of an Observational Multicenter Study to Evaluate the Use and Effectiveness of Avatrombopag in Adult Patients with Immune Thrombocytopenia: The Adopt Study
    McDonald, Vickie
    Matzdorff, Axel
    Mellbring, Asa
    Nazir, Jameel
    Lindqvist, Daniel
    Santagostino, Elena
    BLOOD, 2021, 138
  • [25] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF ROMIPLOSTIM, ATHROMBOPOIETIN (TPO) - RECEPTOR AGONIST, IN THROMBOCYTOPENIC PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN AN EXTENSION STUDY
    Bussel, James
    Tarantino, Michael
    Geddis, Amy
    Guerrera, Michael
    Ikeda, Alan
    Nie, Kun
    Franklin, Janet
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 48 - 48
  • [26] A Final Analysis of a Phase 2, Single-Arm Study of Platelet (Plt) Responses and Remission Rates in Patients with Immune Thrombocytopenia (ITP) Receiving Romiplostim
    Newland, Adrian
    Godeau, Bertrand
    Priego, Victor
    Viallard, Jean-Francois
    Fernandez, Maria Fernanda Lopez
    Orejudos, Amelia
    Lopez, Angela
    BLOOD, 2014, 124 (21)
  • [27] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF ROMIPLOSTIM, A THROMBOPOIETIN (TPO)-RECEPTOR-AGONIST, IN THROMBOCYTOPENIC PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN AN EXTENSION STUDY
    Tarantino, Michael
    Bussel, James
    Geddis, Amy
    Guerrera, Michael
    Ikeda, Alan
    Nie, Kun
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S46 - S46
  • [28] Evaluation Of The Effects Of Long-Term Treatment With Eltrombopag On Bone Marrow In Patients With Chronic Immune Thrombocytopenia (ITP) - Data From The EXTEND Study
    Brynes, Russell K.
    Orazi, Attilio
    Bakshi, Kalpana
    Bailey, Christine K.
    Chan, Geoffrey W.
    BLOOD, 2013, 122 (21)
  • [29] RESULTS FROM A PHASE IV OPEN-LABEL STUDY EVALUATING CHANGES IN BONE MARROW MORPHOLOGY IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) PATIENTS RECEIVING ROMIPLOSTIM: ANALYSIS OF THE 1-YEAR ROMIPLOSTIM COHORT
    Rodeghiero, F.
    George, J.
    Rummel, M.
    Anderson, D.
    Chong, B.
    Boda, Z.
    Hellmann, A.
    Wang, X.
    Woodard, P.
    HAEMATOLOGICA, 2012, 97 : 425 - 425
  • [30] ELTROMBOPAG AS SECOND LINE THERAPY IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN ATTEMPT TO ACHIEVE LONG-TERM REMISSION. UPDATED RESULTS OF A PHASE II, MULTICENTER, PROSPECTIVE STUDY BY GIMEMA GROUP (THE ESTIT STUDY)
    Lucchini, E.
    Palandri, F.
    Volpetti, S.
    Vianelli, N.
    Auteri, G.
    Rossi, E.
    Patriarca, A.
    Carli, G.
    Barcellini, W.
    Rotondo, F.
    Consoli, U.
    Valeri, F.
    Santoro, C.
    Crea, E.
    Vignetti, M.
    Boggio, E.
    Dianzani, U.
    Giardini, I.
    Carpenedo, M.
    Rodeghiero, F.
    Fanin, R.
    Zaja, F.
    HAEMATOLOGICA, 2019, 104 : 32 - 32
1234